MoonLake Immunotherapeutics — All Filings
281 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DEFM14A
DEFR14A
DRS
EFFECT
NT 10-Q
POS AM
PREM14A
PRER14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001213900-25-019673 | Mar 3, 2025 | Feb 27, 2025 |
| 8-K | 8-K | 0001821586-25-000004 | Feb 26, 2025 | — |
| 10-K | 10-K | 0001821586-25-000006 | Feb 26, 2025 | Dec 31, 2024 |
| SCHEDULE 13G | — | 0000080255-25-000208 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-000896 | Feb 12, 2025 | — |
| 4 | — | 0001213900-25-005686 | Jan 22, 2025 | Jan 20, 2025 |
| 8-K | CURRENT REPORT | 0001213900-24-110169 | Dec 18, 2024 | Dec 12, 2024 |
| SC 13G/A | — | 0000315066-24-002771 | Nov 12, 2024 | — |
| 8-K | 8-K | 0001821586-24-000028 | Nov 7, 2024 | — |
| 10-Q | 10-Q | 0001821586-24-000029 | Nov 7, 2024 | Sep 30, 2024 |
| 4 | — | 0001213900-24-086271 | Oct 8, 2024 | Oct 4, 2024 |
| SC 13D/A | AMENDMENT NO. 3 TO SCHEDULE 13D | 0000921895-24-002262 | Oct 8, 2024 | — |
| 4 | OWNERSHIP DOCUMENT | 0000921895-24-002263 | Oct 8, 2024 | Oct 4, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-077513 | Sep 11, 2024 | — |
| 10-Q | 10-Q | 0001821586-24-000025 | Aug 7, 2024 | Jun 30, 2024 |
| 8-K | 8-K | 0001821586-24-000024 | Aug 7, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-051263 | Jun 10, 2024 | — |
| 4 | OWNERSHIP DOCUMENT | 0000921895-24-001377 | Jun 10, 2024 | Jun 6, 2024 |
| 4 | — | 0001213900-24-050835 | Jun 7, 2024 | Jun 6, 2024 |
| 4 | — | 0001213900-24-050833 | Jun 7, 2024 | Jun 6, 2024 |
| 4 | — | 0001213900-24-050824 | Jun 7, 2024 | Jun 6, 2024 |
| 4 | — | 0001213900-24-050826 | Jun 7, 2024 | Jun 6, 2024 |
| 4 | — | 0001213900-24-050828 | Jun 7, 2024 | Jun 6, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-050194 | Jun 6, 2024 | Jun 5, 2024 |
| UPLOAD | — | 0000000000-24-005391 | May 13, 2024 | — |
| 10-Q | 10-Q | 0001821586-24-000020 | May 7, 2024 | Mar 31, 2024 |
| CORRESP | — | 0001213900-24-040464 | May 7, 2024 | — |
| 10-K/A | 10-K/A | 0001821586-24-000018 | May 7, 2024 | Dec 31, 2023 |
| 8-K | 8-K | 0001821586-24-000019 | May 7, 2024 | — |
| UPLOAD | — | 0000000000-24-004748 | Apr 29, 2024 | — |
| DEFA14A | DEFA14A | 0001140361-24-021746 | Apr 24, 2024 | — |
| ARS | ARS | 0001140361-24-021749 | Apr 24, 2024 | Dec 31, 2023 |
| DEF 14A | DEF 14A | 0001140361-24-021744 | Apr 24, 2024 | Jun 5, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-021233 | Mar 11, 2024 | Mar 10, 2024 |
| SC 13D/A | AMENDMENT NO. 2 TO SCHEDULE 13D | 0000921895-24-000582 | Mar 5, 2024 | — |
| 4 | — | 0001213900-24-018675 | Feb 29, 2024 | Feb 27, 2024 |
| 4 | — | 0001213900-24-018671 | Feb 29, 2024 | Feb 27, 2024 |
| 8-K | 8-K | 0001821586-24-000007 | Feb 29, 2024 | — |
| 10-K | 10-K | 0001821586-24-000008 | Feb 29, 2024 | Dec 31, 2023 |
| 8-K | CURRENT REPORT | 0001213900-24-016737 | Feb 26, 2024 | — |
| 4 | — | 0001213900-24-016544 | Feb 23, 2024 | Feb 21, 2024 |
| 4 | — | 0001213900-24-016240 | Feb 22, 2024 | Feb 20, 2024 |
| 4 | — | 0001213900-24-015446 | Feb 20, 2024 | Feb 15, 2024 |
| 4 | — | 0001213900-24-014996 | Feb 16, 2024 | Feb 14, 2024 |
| 144 | — | 0001973141-24-000112 | Feb 15, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-024363 | Feb 15, 2024 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0000929638-24-000649 | Feb 14, 2024 | — |
| 144 | — | 0001973141-24-000110 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-023939 | Feb 14, 2024 | — |
| SC 13G | — | 0000315066-24-001326 | Feb 9, 2024 | — |